Scientific Program

  • Day 1
    April 16 (Fri)
  • Day 2
    April 17 (Sat)
Symposium 1. Cutting Edge of Big Data Research in Colorectal Neoplasm April 16 (Fri), 09:00-10:30 Room A
In this session, we will explore the latest knowledge on big data research in colorectal neoplasm. First, we examine recent studies on the prevention of colorectal cancer based on the FIT based screening program, and discuss the future direction. We find out about big data studies on the most appropriate colonoscopy for colon cancer prevention. We understand the risk factors of colon cancer based on big data studies.
09:00-09:20
  • Prevention of Colorectal Cancer in FIT based Screening Program
  • Khay-Guan Yeoh, National University Hospital, Singapore
09:20-09:40
  • Optimal Colonoscopy Surveillance in the Era of Big Data Research
  • Min Seob Kwak, Kyung Hee University, Korea
09:40-10:00
  • Risk and Protective Factors for Colorectal Cancer: Evidence Through Big Data Research
  • Chang Mo Moon, Ewha Womans University, Korea
10:00-10:10
  • Best abstract 1
  • TBD
10:10-10:20
  • Best abstract 2
  • TBD
10:20-10:30 Discussion
KASID-JSIBD Joint Symposium. Recent update in epidemiology and therapeutics in IBD April 16 (Fri), 09:00-10:30 Room B
This joint session between KASID and JSIBD will feature the latest updates of epidemiology, prognosis and treatments of inflammatory bowel disease, especially among East Asian populations. In addition, we will discuss recently highlighted therapeutic targets and Artificial Intelligence technology in the treatment of inflammatory bowel diseases.
Topic 1 Evolving Prognosis of IBD Patients in East Asia
09:00-09:20
  • Clinical Characteristics and Long-term Prognosis of UC in Korea
  • Sang Hyoung Park, University of Ulsan, Korea
09:20-09:40
  • Changing Patterns of Surgical Treatment for CD in Japan
  • Takahide Shinagawa, The University of Tokyo, Japan
Topic 2 Optimal Therapeutic Target in IBD: What and How?
09:40-10:00
  • What should be the Therapeutic Target?
  • Hyuk Yoon, Seoul National University, Korea
10:00-10:20
  • Applying AI Technology in Endoscopic Evaluation
  • Kento Takenaka, Tokyo Medical and Dental University, Japan
10:20-10:30 Discussion
Symposium 2. What's New in IBD Guidelines April 16 (Fri), 10:50-12:20 Room A
Guidelines provide high-quality evidence-based recommendations in the management of IBD. In this session, speakers will present an update of the 3rd Korean guidelines for the management of IBD and explore the recently updated guidelines in regard to the monitoring of IBD and surgical treatment of IBD.
10:50-11:10
  • Third Korean Guidelines for the Management of Ulcerative Colitis
  • Soo-Young Na, The Catholic University of Korea, Korea
11:10-11:30
  • Third Korean Guidelines for the Management of Crohn's Disease
  • Seong-Joon Koh, Seoul National University, Korea
11:30-11:50
  • How Essential is Therapeutic Monitoring in IBD?
  • David T. Rubin, The University of Chicago Medicine, USA
11:50-12:10
  • When Do We Consider Surgical Management in IBD?
  • Seung-Bum Ryoo, Seoul National University, Korea
12:10-12:20 Discussion
Symposium 3. Clinical Nutrition and Colorectal Cancer April 16 (Fri), 10:50-12:20 Room B
Colon cancer and issues related to food and nutrition have recently been an area of interest to Gastroenterologist and patients. Nutritional deficiency is an increasingly important issue in patients with colorectal cancer. In this session, we will discuss about various nutritional imbalances that can occur in patients with colorectal cancer and how to cope with them. In addition, this session will deal with diet modifications to help colorectal cancer prevention.
10:50-11:10
  • Vitamin D Deficiency and Colorectal Cancer
  • Hyun Joo Song, Jeju National University, Korea
11:10-11:30
  • The Role of Nutrition in Colorectal Cancer with Cachexia
  • Tae-Geun Gweon, The Catholic University of Korea, Korea
11:30-11:50
  • Diet Issues for Colorectal Cancer Prevention
  • Su Young Kim, Yonsei University Wonju, Korea
11:50-12:10
  • Probiotics in the Prevention and Treatment of Colorectal Cancer
  • Hyoun Woo Kang, Seoul National University, Korea
12:10-12:20 Discussion
Sponsored Symposium 1 April 16 (Fri), 12:20-12:50 Room A
Sponsored Symposium 2 April 16 (Fri), 12:20-12:50 Room B
Sponsored Symposium 3 April 16 (Fri), 12:50-13:20 Room A
Sponsored Symposium 4 April 16 (Fri), 12:50-13:20 Room B
Symposium 4. New Trends in Endoscopic Treatment of Colorectal Neoplasm April 16 (Fri), 13:40-15:10 Room A
This session will feature the latest updates for the management of both small and intermediate-sized colorectal polyps and ways to cope with difficult situations, especially in large colorectal polyps. In addition, this session will also review an optimal treatment strategy for rectal neuroendocrine tumors regarding indications and treatment options for endoscopic resection.
13:40-14:00
  • The Best Method of Endoscopic Resection for Small Colorectal polyps
  • Dong Hoon Baek, Pusan National University, Korea
14:00-14:20
  • Trouble Shooting in Endoscopic Resection of Laterally Spreading Tumor
  • Dae Seong Myung, Chonnam National University, Korea
14:20-14:40
  • Optimal Treatment Strategy of Rectal Neuroendocrine Tumor
  • Hoon Sup Koo, Konyang University, Korea
14:40-15:00
  • New Techniques for Endoscopic Mucosal Resection: Underwater EMR
  • Noriya Uedo, Osaka International Cancer Institute, Japan
15:00-15:10 Discussion
MISGKAI-KASID Joint Symposium. Recent Updates of Mucosal Immunology and Research Technologies in IBD April 16 (Fri), 13:40-15:10 Room B
Recently, substantial progress in the mucosal immune response of IBD has been achieved. The molecular mechanism regarding leukocyte cell migration to the intestine has been intensively studied and Enteric Nervous System and immune interaction has emerged as the key player in the pathogenesis of IBD. This session deals with the recent updates in IBD pathogenesis with respect to the leukocyte migration and Enteric Nervous System-immune cell interaction, as well as research technologies including proteomics and gut on a chip in IBD.
13:40-14:00
  • Proteomics in Translational Research and its Application in IBD
  • Kyunggon Kim, University of Ulsan, Korea
14:00-14:20
  • Immune and Enteric Nervous System interaction in IBD
  • Toshiaki Teratani, Keio University, Japan
14:20-14:40
  • Modulation of Leukocyte Migration in IBD
  • Geom Seog Seo, Wonkwang University, Korea
14:40-15:00
  • Host-Microbiome Cross Talk in a Human Gut-on-a-chip
  • Hyun Jung Kim, The University of Texas at Austin, USA
15:00-15:10 Discussion
Symposium 5. Clinical Data in Real-world Practice of IBD April 16 (Fri), 15:30-17:00 Room A
In this session, we will review recent real-world data of variable biologics defining its effectiveness and safety in inducing and maintaining remission in IBD patients.
15:30-15:50
  • Facts of Biologics and Small Molecules for Ulcerative Colitis: Real-world Evidence
  • Zhihua Ran, Shanghai Jiao-Tong University School of Medicine, China
15:50-16:10
  • Current Biologics for Crohn's Disease: Real-world Evidence
  • Sung Noh Hong, Sungkyunkwan University, Korea
16:10-16:30
  • Side Effects from Treatment: Risk and Management
  • Kyeong Ok Kim, Yeungnam University, Korea
16:30-16:40
  • Best abstract 1
  • TBD
16:40-16:50
  • Best abstract 2
  • TBD
16:50-17:00 Discussion
Medical Insurance Policy Session (*Korean) April 16 (Fri), 15:30-17:00 Room B
This session covers major issues related to healthcare policy in the field of colonic disease in Korea. Regarding lower GI endoscopy, the legal issues and measures for perforation complication related to colonoscopy, the feasibility of introducing colon cancer screening using primary colonoscopy, and the cost of colonoscopy will be discussed. In addition, current status and improvement directions for medical insurance in patients with IBD will also be reviewed.
15:30-15:50
  • Investigation of Colonic Perforation Experiences in Colonoscopy and Development of Intervention Strategies
  • Jae Myung Cha, Kyung Hee University, Korea
15:50-16:10
  • Results and Future Prospects of the Pilot Project for Primary Colonoscopy Examinations
  • Byung Chang Kim, National Cancer Center, Korea
16:10-16:30
  • The Ideality and Reality of the Application of Insurance Benefits on Inflammatory Bowel Disease
  • Sung Hoon Jung, The Catholic University of Korea, Korea
16:30-16:50
  • Are the Costs of Colonoscopy Procedures Appropriate?
  • Hong Sub Lee, Inje University, Korea
16:50-17:00 Discussion
Symposium 6. Learning from Challenging Cases April 17 (Sat), 09:00-10:30 Room A
In this session, we will discuss the therapeutic options for various situations encountered during the management of intestinal diseases. The audience will learn about sequential therapy in patients with IBD, the approach in patients with multiple polyps and patients with bowel obstruction in the elderly from challenging cases.
09:00-09:20
  • Strategies for Sequential Therapies of Biologics in Crohn's Disease
  • Brian L Bressler, University of British Columbia, Canada
09:20-09:40
  • Best Practices on Biologic and Small Molecule Sequencing in Ulcerative Colitis
  • Won Moon, Kosin University, Korea
09:40-10:00
  • The Clinical Approach to the Patient with Multiple Colon Polyps
  • Jongha Park, Inje University, Korea
10:00-10:20
  • Management Strategy for Bowel Obstruction in Elderly
  • Yunho Jung, Soon Chun Hyang University, Korea
10:20-10:30 Discussion
Symposium 7. IBD and Nutrition April 17 (Sat), 09:00-10:30 Room B
Nutrient deficiencies are frequent in patients with inflammatory bowel disease (IBD). Therefore, it is very important to establish the optimal nutritional support for IBD patients. In this session, we will discuss the issue of nutritional deficiency and diet education in patients with IBD. We will also discuss the roles of enteral nutrition and parenteral nutrition in pediatric IBD.
09:00-09:20
  • Issues of Nutritional Deficiency in IBD
  • Sang-Bum Kang, The Catholic University of Korea, Korea
09:20-09:40
  • Diet Education for IBD Patients
  • Duk Hwan Kim, Cha University, Korea
09:40-10:00
  • Role of Exclusive Enteral and Parenteral Nutrition in IBD
  • Yeoun Joo Lee, Pusan National University, Korea
10:00-10:20
  • Bone Health in IBD Patients
  • Kyoungmin Kim, Yonsei University, Korea
10:20-10:30 Discussion
Symposium 8. Bench to Bedside Issues in Diagnosis and Management of Colorectal Neoplasm April 17 (Sat), 10:50-12:20 Room A
Knowledge of basic research may eventually be applied to the clinical field, and it can make a substantial contribution to the advance of clinical practice. In this session, we will discuss whether the microbiome, which has recently received much attention, can be used as a diagnostic biomarker for colorectal tumors and how an emerging technology called single-cell analysis can be applied clinical field of colon cancer. Lastly, exosome technology and its capability as a biomarker for colon cancer will also be reviewed.
10:50-11:10
  • Microbiome as Diagnostic Markers in Colorectal Cancer
  • TBD
11:10-11:30
  • Single-cell Sequencing for Translational Cancer Medicine: Progress and Prospects in Colon Cancer
  • TBD
11:30-11:50
  • Circulating Exosomes and Exosomal MicroRNAs as Biomarkers in Colon Cancer
  • Han Sang Kim, Yonsei University, Korea
11:50-12:00
  • Best abstract 1
  • TBD
12:00-12:10
  • Best abstract 2
  • TBD
12:10-12:20 Discussion
KASID-GEST Joint Symposium. Application of Artificial Intelligence in Colorectal Neoplasia April 17 (Sat), 10:50-12:20 Room B
Artificial intelligence (AI) technology has achieved significant development and shown promising achievement in the diagnosis and treatment of colorectal neoplasm. It could help improve the quality of colonoscopy including polyp detection and histologic prediction. It can be also applied to the radiologic evaluation and treatment of colorectal neoplasm. In this session, the clinical application of AI technology in various diagnostic tools and treatments for colorectal neoplasm will be presented and discussed.
10:50-11:10
  • Artificial Intelligence for Endoscopic Diagnosis of Colorectal Neoplasia
  • Chen-Ya Kuo, Fu Jen Catholic University Hospital, Taiwan
11:10-11:30
  • Artificial Intelligence for Radiologic Diagnosis of Colorectal Neoplasia
  • Seong Ho Park, University of Ulsan, Korea
11:30-11:50
  • Artificial Intelligence for Pathologic Evaluation of Colorectal Neoplasia
  • Joe Yeh, AetherAI, Taiwan
11:50-12:10
  • Artificial Intelligence for Medical Management of Colorectal Cancer
  • Yoon Jae Kim, Gachon University, Korea
12:10-12:20 Discussion
Sponsored Symposium 5 April 17 (Sat), 12:20-12:50 Room A
Sponsored Symposium 6 April 17 (Sat), 12:20-12:50 Room B
KASID General Meeting April 17 (Sat), 12:50-13:30 Room A
KASID Plenary Session April 17 (Sat), 13:50-14:50 Room A
Editorial Session (*Korean) April 17 (Sat), 13:50-14:50 Room B
In this session, we will reflect on the importance of research ethics and identify the latest trends in medical publishing, and discuss future academic journal directions.
13:50-14:05
  • Authorship and Real-name System
  • Sung-Tae Hong, Seoul National University, Korea
14:05-14:20
  • Recent Trends in Medical Journal Publication
  • Hye-Min Cho, InfoLumi, Korea
14:20-14:35
  • The Future Path of Academic Journals: Lessons from Past Experience
  • Sun Huh, Hallym University, Korea
14:35-14:50 Discussion
Combined Session. Multi-omics Diagnosis of Colorectal Disease April 17 (Sat), 14:50-16:20 Room A
Multi-omics technologies have the potential as useful tools for the fulfillment of individualized precision medicine in gastroenterology. In this session, the application and perspective of multi-omics technology in the field of colorectal neoplasia and inflammatory bowel disease will be explored.
14:50-15:15
  • Multi-omics Approach: A New Frontier in Intestinal Research
  • Woong-Yang Park, Sungkyunkwan University, Korea
15:15-15:40
  • Multi-omics Landscape to Reveal Driving Factors in Colorectal Cancer
  • TBD
15:40-16:05
  • Integrating Omics for Inflammatory Bowel Disease in the Era of Precision Medicine
  • Jae Hee Cheon, Yonsei University, Korea
16:05-16:20 Discussion
Closing April 17 (Sat), 16:20-16:30 Room A
Nurse Forum (*Korean) April 16(Fri) -17 (Sat), All Day Virtual
  • Efficacy, Safety and Practice Caution of Biologics and Small Molecule for IBD
  • Jun Lee, Chosun University, Korea
  • Disease Monitoring and Optimal Therapeutic Strategy in IBD
  • Ki Bae Bang, Dankook University, Korea
  • Telemedicine for the Management of IBD
  • Eun Mi Song, Ewha Womans University, Korea
  • IBD Management in the COVID-19 Pandemic
  • Jee Hyun Kim, CHA University, Korea